Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biovitrum

Biovitrum is one of the largest biopharma companies in Europe. We combine research and development with process development and production of protein-based drugs and marketing of specialist pharmaceuticals.


Contact Details:
Stockholm
SE-112 76
Sweden
Tel:46 8 697 20 00
Fax:
Email:info@biovitrum.com
WWW:

www.biovitrum.com/




Recent Publications by Biovitrum:

A versatile new synthetic route to 1N-hydroxyindazoles.
A new and versatile cyclization reaction affording rare...
10th October, 2009
Biovitrum AB, Discovery Research, 112 76 Stockholm, Sweden. Org Lett. 2009 Nov 5;11(21):5078-81.
DOI Direct Link
N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP)...
21st August, 2009
Department of Medicinal Chemistry, Biovitrum AB, Research, 112 76 Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8. Epub 2009 Jan 30.
DOI Direct Link
Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice.
BACKGROUND: A substantial body of evidence indicates that reduced plasma...
21st August, 2008
Biovitrum, BMC Pharmacol. 2008 Feb 12;8:3.
DOI Direct Link
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) has attracted...
10th July, 2008
Biovitrum J Med Chem. 2008 May 22;51(10):2933-43. Epub 2008 Apr 18.
DOI Direct Link
Molecular dynamics studies of alpha-helix stability in fibril-forming peptides.
Diseases associated with protein fibril-formation, such as the prion...
5th June, 2008
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, J Comput Aided Mol Des. 2008 Jan;22(1):53-8. Epub 2007 Dec 6.
DOI Direct Link

View more Biovitrum research publications.

Press Releases on Biovitrum:

BioPortfolio Logo
Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development 23rd April, 2009
STOCKHOLM, April 23 /PRNewswire/ -- Pharmalink AB today announced that it has strengthened its Board of Directors as the company's portfolio continues to move towards late stage product
BELLUS Health announces closing of Innodia acquisition 17th July, 2008 BELLUS HEALTH INC.
LAVAL, QC, July 17 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today the closing of the acquisition of Innodia Inc. that it had
SYMPHOGEN ANNOUNCES USD 25 MILLION FINANCING FROM INTERNATIONAL INVESTORS 1st November, 2004 Symphogen
SYMPHOGEN ANNOUNCES USD 25 MILLION FINANCING FROM INTERNATIONAL INVESTORS  Copenhagen , Denmark , 2 November 2004 : Symphogen A/S, the Danish biotech company pioneering recombinant
Takeda makes strategic investment in Lectus Therapeutics 1st May, 2004 Datamonitor
Takeda makes strategic investment in Lectus Therapeutics Through its venture capital arm, Takeda has recently invested in three emerging biotechnology ventures, including Lectus Therapeutics,
Northbank Communications Strengthens PR Team with the Appointment of Dr 1st May, 2004 Northbank
Northbank Communications Strengthens PR Team with the Appointment of Dr Douglas Pretsell as Account Manager London, Manchester, Munich, 13th May 2004 … Northbank

BioNews Results for Biovitrum:

Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More
Indianapolis Recorder:  Nov 12 2009 1:28AM Matching: biovitrum
Biovitrum Will Pay up to $533M for Swedish Orphan
BioWorld:  Nov 11 2009 7:41AM Matching: biovitrum
Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...
Pharmaceutical Technology:  Nov 11 2009 6:44PM Matching: biovitrum
The creation of a new niche specialty pharmaceutical company focused on rare diseases - with ...
PipelineReview:  Nov 7 2009 10:42PM Matching: biovitrum
Biovitrum and Swedish Orphan to merge
PharmaBiz:  Nov 7 2009 9:45AM Matching: biovitrum
Promote your company here: BioNewsCast - Press Release Distribution

View more Biovitrum news.

Biovitrum Clinical Trials:

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Biovitrum Patents:

US Patent No.Title
6399357 Filtration
6599724 Stable factor VIII compositions
6602977 Receptor structures
6708847 Dispenser for mixing then dispensing multiple components
6709860 Animal model

View more Biovitrum patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 22 individuals from Biovitrum using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 461 times since April 2007, the link to the organisation's website has been followed 105 times

Search for more companies in Stockholm

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biovitrum

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.